Search for Clinical Trial Results
Diamond-Blackfan Anemia - 26 Studies Found
Status | Study |
Recruiting |
Study Name: CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease Condition:
|
Suspended |
Study Name: Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation Condition:
|
Recruiting |
Study Name: Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies Condition:
|
Suspended |
Study Name: Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies Condition:
|
RECRUITING |
Study Name: Study of the Selective GlyT1 Inhibitor Bitopertin for Steroid-Refractory Diamond-Blackfan Anemia Condition: Steroid-refractory Diamond-Blackfan Anemia (DBA) Date: 2024-05-19 Interventions: Dose Escalation: Monthly (every 4 weeks) up to a maximum dose of 60 mg bitopertin (5 mg, 10mg, 20mg, 40mg, 60mg).At each monthly (4 week) interv |